We have reported previously1~3) the discovery, isolation and structures of new cephem antibiotics, cephabacin F1~9 and H1~6 (Table 1) , produced by new species of Lysobacter and Xanthomonas. Here we describe their antibacterial activities, stability to 13-lactamases and inhibitory activity against 8-lactamases, and the mode of action of cephabacin F1 and H1.
Materials and Methods

MIC Determination
MICs were assayed by the conventional agar dilution method with DYAB agar4). The MuellerHinton medium (Difco) was used for an assay against (3-lactamase-producing bacteria.
Assay of Stability to 8-Lactamases
The rate of hydrolysis by (3-lactamases was determined spectrophotometrically by monitoring the decrease of optical density at 265nm5). The differences in molar extinction (M-1•cm-1) between antibiotics and the corresponding hydrolyzed compounds (hydrolyzed by the Pseudomonas aeruginosa U31 (3-lactamase or 0.75 N NaOH) at 265 nm were as follows: Cephabacin F1 7,640; F. 8,260; F3 8,480; H, 6,520; H2 5,960; H3 5,670; 7-formylaminodeacetylcephalosporin C 7,390; deacetylcephalosporin C 6,100; cephamycin C 3,260. For the 8-lactamase-resistant substrates, hydrolysis rates were determined microbiologically; an aliquot withdrawn at intervals from the reaction mixture was added to nine volumes of MeOH and the residual amount of antibiotic was assayed by the paper disk method with E. coli PG-86). The enzyme activities with benzylpenicillin and cephaloridine as substrates were determined microiodometrically5).
Assay of (3-Lactamase Inhibitory Activity /3-Lactamase inhibitory activity was determined as described previously7). The percent inhibi-tion of enzyme activity was calculated against a control reaction in which the inhibitor was replaced by buffer. The concentration giving 50% inhibition (I50) was obtained from a plot of the percentage inhibition against the antibiotic concentration.
Assay of Lytic Activity
Cultures of E. coli LD-2 and B. subtilis PCI 219 grown in DYAB medium to the exponential phase were diluted 5-fold with fresh medium. Portions of 4.5 ml of the diluted cultures were delivered into sterilized tubes which were then incubated at 37°C with reciprocal shaking. After 3 hours incubation, 0.5 ml of an antibiotic solution was added to the culture. Growth was followed by measuring the absorbance at 600 nm every hour with a Spectronic 20 colorimeter (Shimadzu, Bausch & Lomb).
Determination of Inhibition of Peptidoglycan Synthesis Peptidoglycan synthesis was assayed by incorporation of [G-3H]diaminopimelic acid (281 mCi/ mmol, Amersham) into hot TCA-insoluble fractions using E. coli LD-2 and B. subtilis PCI 219".
Assay of Affinity for Penicillin-binding Proteins (PBPs) The affinity of PBPs in E. coli LD-2 was assayed as described previously4). The assay of affinity for PBPs in B. subtilis PCI 219 was carried out by the method of GEORGOPAPADAKOu and LIE8) except for the SDS-PAGE and fluorography procedures. These procedures were those used with E. coli LD-2.
Protective Effect in Mice Mice were infected intraperitoneally with 0.5 ml of a suspension of E. coli 0-1111). Groups of five mice at each dose level were subcutaneously given 0.2 ml of an antibiotic solution immediately after infection. The 50% effective dose (ED,, mg/kg) was calculated by the conventional method from the survival rate at 5 days after infection.
Results
Antibacterial Activities
Cephabacin F,_, showed moderate antibacterial activity against a wide range of Gram-negative and Gram-positive bacteria. They were highly active against Alcaligenes faecalis and Acinetobacter calcoaceticus. On the other hand, cephabacin H1~6 were less active against Gram-negavite bacteria but more active against Gram-positive bacteria than cephabacin F1~9 (Table 2) . of cephabacins and related compounds.
MIC (ug/ml) at 106 cfu/ml a Expressed as relative rate of hydrolysis , taking the rate for benzylpenicillin (penicillinase), or cephaloridine (cephalosporinase) as 100. b 7-FD , 7-formylaminodeacetylcephalosporin C; DCPC, deacetylcephalosporin C; CMC, cephamycin C.
As shown in Table 3 , cephabacin F group antibiotics exerted antibacterial activity against (3-lactamase-producing clinical isolates as potent as against their non-producing counterparts. Cephabacin F, was also active against anaerobic organisms such as Bacteroides fragilis (MIC 25 µg/ml) and Clostridium perfringens (MIC 25 jig/ml).
The 3-side chains of cephabacins clearly had positive effects on their antibacterial activities, that is, cephabacin F and H group antibiotics were more active than their corresponding derivatives without the 3-side chains, namely 7-formylaminodeacetylcephalosporin C and deacetylcephalosporin C, respectively (Tables 2 and 3 ). 
Stability to 3-Lactamases
As shown in Table 4 , cephabacin F group antibiotics were highly resistant to hydrolysis by various types of 6-lactamases whereas cephabacin H group antibiotics were sensitive, especially to the cephalosporinases. 7-Formylaminodeacetylcephalosporin C was also far more stable to the p-lactamases than deacetylcephalosporin C. The cephalosporins with a 7-formylamino substituent were far more stable to the 3-lactamases than cephamycin C, a 7-methoxycephalosporin.
The differences in the 3-side chain exhibited no significant effect on the susceptibility of cephabacin antibiotics to p-lactamases.
B -Lactamase Inhibitory Activity
Cephabacin F1~4,7 showed inhibitory activity against a cephalosporinase of Proteus vulgalis GN 4413. This inhibition was 100-fold greater than that shown by cephabacin H,_3 (Table 5 ). Cephabacin
F group antibiotics appears to be generally more inhibitory to this enzyme than cephabacin H group THE JOURNAL OF ANTIBIOTICS DEC. 1984 antibiotics because the former antibiotics showed far more inhibitory activity than the latter antibiotics in the convenient assay system, i.e., the St/Si system described in the preceding paper1) (data not shown).
However, cephabacins did not show inhibitory activity against 19-lactamases of S. aureus, E. coli (TEM-1) and Enterobacter cloacae. a The 150 for each PBP was quantitated with the fluorograms shown in Fig . 3 . b The affinity for PBP 516 was positive but not quantitated .
Mode of Action
In order to elucidate the mode of action of cephabacins, various biological activities of cephabacin Fl and Hl were examined using E. coli LD-2 and B. subtilis PCI 219 as the test organisms. Cephabacin
Fl and H, specifically inhibited peptidoglycan synthesis among intracellular synthesis of macromolecules, i.e., DNA, RNA, protein and peptidoglycan in E. coli LD-2 (data not shown). The in-hibitory activity of cephabacin F1 for peptidoglycan synthesis was more potent than that of cephabacin H1 in E. coli LD-2 whereas the results were vice versa in B. subtilis PCI 219 (Fig. 1); these relationships paralleled the antibacterial activities against these organisms (MICs shown in Fig. 1 by the arrows) . At the equivalent doses, cephabacin F1 showed higher lytic activity against E. coli LD-2 than cephabacin H1 whereas they showed similar activity against B. subtilis PCI 219 (Fig. 2) . As shown in Fig. 3A , cephabacin F1 showed the highest affinity for PBP I in E. coli LD-2 among the lethal targets (PBP 1, 2 and 3) in this organism10). On the other hand, cephabacin F1
showed the highest affinity for PBP 4 among the possible lethal targets (PBP 1,2 and 4) in B. subtilis11.12) (Fig. 3B ). The concentrations of cephabacin F1 required to inhibit the binding of [14C]benzylpenicillin by 50% to PBP IA and lB in E. coli LD-2 and to PBP 4 in B. subtilis PCI 219 were consistent with the MICs against these organisms (Table 6) .
To obtain information on the effects of the 7-formylamino substituent and the 3-side chains of cephabacins on the affinities for PBPs in E. coli, we compared the affinities of cephabacins F1 and H1, 7-formylaminodeacetylcephalosporin C and deacetylcephalosporin C. The results led to the conclusion that the complex 3-side chains increases the affinity for PBPs although the 7-formylamino substituent does not significantly affect the affinity for PBPs (data not shown). Cephabacins protected mice from intraperitonial infection by E. coli 0-111 (Table 7) .
Discussion
Based on the data on the antibacterial activities and the stability to ~-lactamases of cephabacins, the following conclusions on the structure-activity relationships of cephabacin antibiotics have been drawn: 1) The 7-formylamino substituent is the only factor of cephabacin F group antibiotics necessary for the stability to p-lactamases and seems to be a more efficient substituent for confering the stability to cephem antibiotics than the 7-methoxy one (Table 4) , 2) the 7-formylamino substituent increases the antibacterial activity against Gram-negative bacteria while it decreases that against Gram-positive bacteria (Table 2) , 3) the presence or absence of the guanidyl group and the difference between L-alanine and L-serine residues in the 3-side chains do not influence the activity, and 4) the greater the number of L-alanine or L-serine residues in the 3-side chain is, the weaker are the antibacterial activities of cephabacins (Tables 2 and 3 ).
The inhibitory activities of cephabacin F group antibiotics against the P. vulgaris GN 4413 8-lactamase were 100-fold stronger than those of cephabacin H group antibiotics, but that of 7-formylaminodeacetylcephalosporin C was almost the same as those of cephabacin H group antibiotics and deacetylcephalosporin C (Table 5 ). This observation leads to the conclusion that both the 7-formylamino substituent and the 3-side chains of cephabacin F group antibiotics contribute to the potent inhibitory activity against this enzyme.
Cephabacin F1 showed the highest affinity for PBP I among the lethal targets, i.e., PBP 1, 2 and 3, in E. coli (Table 6 ). Furthermore, its affinities for PBP 2 and 3 were quite low; to our knowledge, it is the most specific inhibitor of PBP 1 in E. coli among p-lactam antibiotics tested in their binding affinities. These results agree well with its potent lytic activity (Fig. 2) without inducing filamentous or ovoid cells and its inhibitory activity on peptidoglycan synthesis in E. coli (Fig. 1) . Cephabacin F1 also showed good affinity for PBP 4 and 5/6 in E. coli, D-alanine carboxypeptidases13,14), as did 7-methoxycephalosporins1S,lsl; this seems to be a common property of cephalosporins with the formylamino or the methoxy substituent at the 7-position.
Comparison of the affinities of cephabacin F1 and 7-formylaminodeacetylcephalosporin C, and those of cephabacin H1 and deacetylcephalosporin C demonstrated that the complex 3-side chains of cephabacins clearly increased the affinity for PBPs in E. coli.
STROMINGER et al. suggested that PBP 1, 2 and 4 could be lethal targets in B. subtilis11,12). Among these PBPs in B. subtilis, cephabacin F1 bound PBP 4 with the highest affinity (Table 6 ). However, discussion of the mode of action of cephabacins in this organism requires further study of the functions of these PBPs.
